tirzepatide/b12 injection Injectable (68mg/8mg) Tirzepatide, Glycine + Vitamin B12

The SURMOUNT-1 Phase 3 trial published in the New England Journal of Medicine demonstrated 20.9% mean body weight reduction at 72 weeks on tirzepatide 15mg weekly versus 3.1% with placebo

Water retention (typically mild) with sustained GH elevation

This is achieved by modulating 2 main processes , which are stimulating lipolysis and inhibiting lipogenesis

9.6 for placebo Patients in randomized clinical study Adverse events reported across all treatment groups AHK-Cu first shown to stimulate dermal papilla cell proliferation while inhibiting follicle apoptosis Lee WJ et al., Annals of Dermatology, 2016 (PMID: 27489425) Pickart L, J Biomater Sci, 2008 (PMID: 18644225) Shin HS et al., Archives of Pharmacal Research, 2007 (PMID: 17703734) The Formula Two Copper Peptides

Here's how: Continue injections until B12 levels normalize Begin daily sublingual spray supplementation Gradually reduce injection frequency under medical supervision Monitor B12 levels with blood tests Maintain daily spray for ongoing support Always consult your healthcare provider before making changes to your B12 treatment plan

Unlike full-length hGH, AOD9604 does not bind the growth hormone receptor and does not elevate IGF-1 or interfere with glucose homeostasis in published research models a distinction that has made it a valuable comparator compound in metabolic studies